4-Aminosalicylic acid

Molecular mass: 153.135 g/mol  PubChem compound: 4649

Active ingredient description

Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis. It inhibits the onset of bacterial resistance to streptomycin and isoniazid.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J04AA01 Aminosalicylic acid J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AA Aminosalicylic acid and derivatives
Discover more medicines within J04AA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
GRANUPAS Gastro-resistant granules European Medicines Agency (EU) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 65-49-6
DrugBank Drug: DB00233
KEGG Drug: D00162
PubChem Compound: 4649
RxNorm Ingredient: 7833
SNOMED-CT Concept: 27192005
Aminosalicylic acid (substance)
UNII Identifier: 5B2658E0N2
AMINOSALICYLIC ACID

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.